Background The treatment, genotyping, and phenotyping of patients with World Health
Organization Group 1 pulmonary arterial hypertension (PAH) have evolved dramatically in …

Pulmonary arterial hypertension (PAH) can cause morbidity and mortality in children.
Although adult and pediatric PAH share many similarities, many differences have been …

Pulmonary arterial hypertension (PAH) is a chronically progressive fatal disease. A goal‐
oriented approach to achieve low risk status has been associated with improved survival. A …

Purpose Pulmonary hypertension (PH) is a heterogenous, often progressive disorder
leading to right heart failure and death. Previous analyses show stable PH mortality rates …

Objectives This study assessed pulmonary hypertension (PH)-related hospitalizations,
including readmissions, among US patients with pulmonary arterial hypertension (PAH), a …

Abstract Purpose of Review Pediatric pulmonary arterial hypertension (PAH) is associated
with significant morbidity and mortality. Herein we review the diagnosis and classification for …

BACKGROUND: Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal
disease associated with considerable overall clinical and economic burden. Although the …

Background Pulmonary arterial hypertension is a rare, progressive disease with poor
prognosis. However, there is limited information available on the characteristics of PAH …

Background Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Little is
known about the economic burden associated with PAH patients in the US. Objectives The …

The past decade has witnessed extensive progress in basic and clinical research in the field
of pulmonary hypertension (PH), a group of chronic conditions characterised by high …